Loading…
Innoviva, Inc. is projected to rise to $27.48 by 2027, a +24% move from its current price of $22.13. INVA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $21.86 | $22.15 | $22.44 | +0.08% |
| May 30 | $21.76 | $22.17 | $22.58 | +0.16% |
| May 31 | $21.69 | $22.18 | $22.69 | +0.24% |
| Jun 1 | $21.63 | $22.20 | $22.79 | +0.32% |
| Jun 2 | $21.58 | $22.22 | $22.88 | +0.40% |
| Jun 3 | $21.54 | $22.24 | $22.96 | +0.48% |
| Jun 4 | $21.50 | $22.25 | $23.04 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $21.50 | $22.25 | $23.04 | +0.56% |
| Week 2 | $21.31 | $22.38 | $23.50 | +1.11% |
| Week 3 | $21.19 | $22.50 | $23.89 | +1.67% |
| Week 4 | $21.11 | $22.63 | $24.24 | +2.24% |
| Week 5 | $21.06 | $22.75 | $24.58 | +2.81% |
| Week 6 | $21.02 | $22.88 | $24.90 | +3.38% |
| Week 7 | $20.99 | $23.00 | $25.21 | +3.95% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. It is headquartered in Burlingame, California. The company’s royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of vilanterol and an inhaled corticosteroid, and fluticasone furoate; it also markets ANORO ELLIPTA, a once-daily medicine combining umeclidinium bromide and ABA, VI.
Innoviva was formerly known as Theravance, Inc., and changed its name to Innoviva, Inc. in January 2016. Innoviva was incorporated in 1996 and is headquartered in Burlingame, California.
INVA is currently priced at $22.46, with a market cap of $1.66B and a rank of 2146. The 30-day technical snapshot shows the stock trading near a support/resistance zone with a low of $20.66 and a high of $24.41 in the period, and near that range the price direction is expected to evolve. The year-by-year forecast points to a rising price trajectory, with 2026 averaging $22.46 and 2050 averaging $259.78, reaching a max of $425.11 in 2050 and delivering an overall ROI of 1056.7% by 2050.
A major floor 12.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.8% away) — a key level to hold.
The nearest ceiling, 9.5% above — a clean break opens room to run.
A major ceiling 13.9% above — clearing it would confirm fresh momentum.
Key INVA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INVA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $22.34 | Sell | $22.31 | Sell |
| MA 10 | $22.32 | Sell | $22.37 | Sell |
| MA 20 | $22.57 | Sell | $22.57 | Sell |
| MA 50 | $22.93 | Sell | $22.67 | Sell |
| MA 100 | $22.15 | Sell | $22.19 | Sell |
| MA 200 | $20.90 | Buy | $21.28 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.96 | Neutral |
| Stoch RSI (14) | 48.89 | Neutral |
| CCI (20) | -82.32 | Neutral |
| Williams %R (14) | -71.63 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -3.32 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 28.37 | Neutral |
| TRIX (15) | -0.15 | Sell |
| Awesome (5,34) | -0.73 | Sell |
| Ultimate (7,14,28) | 49.88 | Neutral |
| Momentum (10) | -0.61 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 22.51 | Sell |
| ADX (14) | 13.81 | Neutral |
| ATR (14) | 0.29 | Info |
The 30-day technical picture is bullish overall. RSI14 is 50, with the 50-day simple moving average at $22.92 and the 200-day simple moving average at $20.86. Near-term support sits at $21.73 and resistance at $24.24, framing a 30-day range from $20.66 to $24.41.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.31 | $22.13 | $29.59 | 0% | Neutral | |
| $22.45 | $27.48 | $35.22 | +24% | Bullish | |
| $27.23 | $33.94 | $44.63 | +53% | Bullish | |
| $32.27 | $40.83 | $54.79 | +84% | Bullish | |
| $35.01 | $44.89 | $61.31 | +103% | Bullish | |
| $39.31 | $51.02 | $70.77 | +131% | Bullish | |
| $41.09 | $53.91 | $75.84 | +144% | Bullish | |
| $42.53 | $56.39 | $80.34 | +155% | Bullish | |
| $48.24 | $64.59 | $93.12 | +192% | Bullish | |
| $54.79 | $74.05 | $107.93 | +235% | Bullish | |
| $78.07 | $110.03 | $168.01 | +397% | Bullish | |
| $160.53 | $242.62 | $397.00 | +996% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $19.31 | $22.13 | $25.95 | +0.00% |
| June 2026 | $19.77 | $23.07 | $27.43 | +4.24% |
| July 2026 | $20.27 | $23.79 | $28.55 | +3.11% |
| August 2026 | $20.01 | $23.59 | $28.52 | -0.83% |
| September 2026 | $20.00 | $23.66 | $28.77 | +0.29% |
| October 2026 | $20.47 | $24.30 | $29.72 | +2.72% |
| November 2026 | $20.42 | $24.31 | $29.87 | +0.06% |
| December 2026 | $20.08 | $23.98 | $29.59 | -1.39% |
Click any year to see its month-by-month INVA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, INVA could reach as high as $29.59, with a base case around $22.13 and support toward $19.31 — roughly 0% from $22.13. A consolidation phase looks the most probable path here.
Expect INVA to range from $22.45 to $35.22 through 2027. The $27.48 average target implies a +24% move from current prices. That is up +24% on the projected 2026 average. Momentum favours further upside here.
The INVA price prediction for 2028 points to an average of $33.94 (low $27.23, high $44.63) — a potential gain of +53% on today's $22.13. Buyers look set to stay in control over this stretch.
In 2029, INVA is projected to trade between $32.27 and $54.79, averaging $40.83 — a potential gain of +84% from today's $22.13. That is up +20% on the projected 2028 average. Momentum favours further upside here.
Innoviva, Inc.'s 2030 outlook centres on $44.89, within a $35.01 to $61.31 range. That is up +10% on the projected 2029 average. That marks a +103% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, INVA could reach as high as $70.77, with a base case around $51.02 and support toward $39.31 — roughly +131% from $22.13. Momentum favours further upside here.
Expect INVA to range from $41.09 to $75.84 through 2032. The $53.91 average target implies a +144% move from current prices. That is up +6% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The INVA price prediction for 2033 points to an average of $56.39 (low $42.53, high $80.34) — a potential gain of +155% on today's $22.13. Momentum favours further upside here.
In 2034, INVA is projected to trade between $48.24 and $93.12, averaging $64.59 — a potential gain of +192% from today's $22.13. That is up +15% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Innoviva, Inc.'s 2035 outlook centres on $74.05, within a $54.79 to $107.93 range. That is up +15% on the projected 2034 average. That marks a +235% change versus current levels. Momentum favours further upside here.
By 2040, INVA could reach as high as $168.01, with a base case around $110.03 and support toward $78.07 — roughly +397% from $22.13. Buyers look set to stay in control over this stretch.
Expect INVA to range from $160.53 to $397.00 through 2050. The $242.62 average target implies a +996% move from current prices. That is up +120% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in INVA today (≈ 45.187528 INVA) could be worth
$10,963.53
+$9,963.53 (+996%) by 2050 · US Dollar
Based on the average projected INVA price of $242.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INVAwould be worth at today's price.
$1,000 invested in INVA on May 27, 2025 (≈ 52.219322 INVA) would be worth
$1,155.61
+$155.61 (+15.6%) today · 1.16× · US Dollar
Based on a INVA entry price of $19.15 vs. today's $22.13.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22.24 | $995.05 | -0.5% |
| 1 month ago | $23.36 | $947.35 | -5.3% |
| 3 months ago | $23.54 | $940.1 | -6.0% |
| 6 months ago | $21.73 | $1,018.41 | +1.8% |
| 1 year ago | $19.15 | $1,155.61 | +15.6% |
| All time (5.0y) ago | $13.51 | $1,638.05 | +63.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INVA forecast.
Our base-case forecast reaches $44.00 around 2030.
Implied market cap at $44.00: $3.25B
Looking at the multi-year forecast, the average price rises from $46.84 in 2030 with an ROI of 108.5% (min $36.53, max $63.99), to $116.52 in 2040 with an ROI of 418.8% (min $82.66, max $177.93), and to $259.78 in 2050 with an ROI of 1056.7% (min $171.87, max $425.11). The sequence also shows 2035 with an average of $78.47 and a max of $114.39 (ROI 249.4%), 2031 with an average of $52.99 (ROI 135.9%), and 2032 with an average of $56.35 (ROI 150.9%). Across years, the forecast carries a bullish sentiment from 2027 onward, reflecting a strong longer-term upward path, albeit within a framework of 20% annualized volatility.
These estimates are not guarantees and carry inherent uncertainty.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $46.84, with a low of $36.53 and a high of $63.99, for an ROI of 108.5%.
The forecast indicates a bullish trajectory from 2027 onward, with the average price rising to $259.78 by 2050 and an ROI up to 1056.7%. These figures are estimates and do not guarantee future results.
Yes. The forecast shows years with higher price levels, including a 2035 max of $114.39 and a 2040 max of $177.93, rising toward a 2050 max of $425.11.
For 2040, the average price is forecast at $116.52, with a min of $82.66 and a max of $177.93, and an ROI of 418.8%.
Current price is $22.46 and market cap is $1.66B.
Innoviva, Inc. Community Discussion
0Share your Innoviva, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.